Marthe Boevre PhD

Marthe De Boevre was born in Ghent (Belgium) on February 7th, 1986. In 2013 dr. Marthe De Boevre graduated from the Faculty of Pharmaceutical Sciences (Ghent University) with a Ph.D. in ‘Chemical risks related to food and feed containing masked Fusarium mycotoxins’ under the supervision of Prof. Dr. Carlos Van Peteghem and Prof. Dr. Sarah De Saeger. To date, she coordinates the research line ‘clinical mycotoxicology’ within the research framework of the Centre of Excellence in Mycotoxicology & Public Health & the Department of Bioanalysis at Ghent University.

Dr. Marthe De Boevre investigates the impact of multiple mycotoxins as potential contributing factors on human carcinomas and other adverse health effects within multiple (inter)national research projects with partners at WHO-IARC, Medical University Groningen, University of Liverpool, CAAS Beijing, University of Aveiro, a.o. In addition, she is the coordinator of the ITN UGent MYTOX-SOUTH®, which is an intercontinental partnership to improve food security & food safety through the mitigation of mycotoxins at the global level. This well-structured multi-disciplinary partnership, which deals with all known aspects of mycotoxins and toxigenic mold issues, is able to provide the most adequate strategies and solutions for different stakeholders covering both fundamental and applied research. In 2019, dr. Marthe De Boevre and her team received the CRIG Young Investigators proof-of-concept grant (YIPOC grant). The concept of YIPOC and preliminary data derived from other external funding resources such as FWO and BOF formed the backbone for a research section in the ERC StG project HUMYCO. From February 2021 onwards, she will be appointed as Professor in Clinical Mycotoxicology at Ghent University.